As shown in Fig. 2a, SLC1A5 expression was significantly associated with OS (P < 0.001) of ccRCC patients, and so that means higher SLC1A5 expression indicated earlier death. This evidence concerns the gene SLC1A5 and nonpapillary renal cell carcinoma.